KFDA approves simvastatin CR’s intake anytime

Published: 2009-11-18 06:56:00
Updated: 2009-11-18 06:56:00
Hanmi Pharm says it has received approval from the Korea Food and Drug Administration to administer simvastatin controlled release (CR) tablet without restriction in the morning or at night.

For simvastatin, the evidence is that marginally better lowering of total and LDL cholesterol comes fro...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.